Hydreight Technologies Inc (NURS) Price & Analysis

Compare

28 Followers

NURS Stock Chart & Stats

C$4.55

Market closed

C$4.55

Day’s Range― - ―

52-Week RangeC$1.00 - C$5.59

Previous CloseN/A

VolumeN/A

Average Volume (3M)151.18K

Market Cap

C$135.01M

Enterprise ValueC$75.16M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)464.3

Beta0.83

Next Earnings

May 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.01

Shares Outstanding29,673,117

10 Day Avg. Volume81,450

30 Day Avg. Volume151,176

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

C$8.50

Price Target Upside86.81% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Market ExpansionHydreight aims to expand access to care through its 'Uber'-like nurse network to offer services to any location, and a 'Shopify'-like platform to launch direct-to-consumer (DTC) healthcare brands.

Revenue GrowthHydreight is expected to achieve significant growth in revenue and adjusted EBITDA over the next few years, with the highest organic growth rate among covered companies.

Strategic PartnershipsThe acquisition of a 5% stake in Perfect Scripts and the related partnership are expected to secure pharmaceutical distribution at lower costs.

Bears Say

Hydreight Technologies Inc News

Hydreight enters distribution agreement with Health Screen Collective

Hydreight Technologies (HYDTF) announced its entry into the rapidly expanding at-home sexually transmitted infection pre-screening market through an...

16d ago

Hydreight Technologies exceeds 1.3M product orders placed

Hydreight Technologies (HYDTF) provides an update on the Company’s recent operational performance and platform activity. Operational Highlights: Exceeded...

29d ago

Hydreight Raises C$10 Million in Bought Deal to Accelerate U.S. Digital Healthcare Growth

Hydreight Technologies Inc ( ($TSE:NURS) ) has shared an announcement. Hydreight Technologies Inc. has launched a C$10 million...

13h ago

Hydreight Moves Into At-Home STI Testing With Exclusive Deal and 50,000 Pre-Orders

Hydreight Technologies Inc ( ($TSE:NURS) ) has shared an announcement. Hydreight Technologies has entered the at-home sexually transmitted...

16d ago

Hydreight Beats 2025 Targets With 1.3 Million Orders and Rapid License Growth

An update from Hydreight Technologies Inc ( ($TSE:NURS) ) is now available. Hydreight Technologies has surpassed 1.3 million...

29d ago

Hydreight Technologies announces update highlighting Q3 momentum

On November 26, 2025, Hydreight reported its Q3 2025 financial and operational results in a release titled “Hydreight...

1M ago

Hydreight Technologies says 295,000 VSDHOne orders placed in Q3

For Q3 2025, VSDHOne recorded: about 295,000 product orders placed. As of December 1, 2025: approx. 887,000 total...

1M ago

Hydreight Technologies announces 2026 framework

The Company outlined its initial priorities for 2026: Margin discipline; Increased automation; Stronger onboarding processes; Expanded multi-vertical adoption;...

1M ago

Hydreight Technologies Inc: A Compelling Buy Amidst Growth Potential and Strategic Expansion

Analyst Allen Klee from Maxim Group reiterated a Buy rating on Hydreight Technologies Inc and keeping the price...

1M ago

Hydreight Technologies Secures Strategic Stake in Perfect Scripts

The latest announcement is out from Hydreight Technologies Inc ( ($TSE:NURS) ). Hydreight Technologies Inc. has acquired a...

2M ago

NURS Upcoming Earnings Report: What to Expect?

Hydreight Technologies Inc (NURS) is scheduled to report 3rd quarter earnings on 11/24/2025. Regarding Q3 estimates, Wall Street...

2M ago

NURS

Hydreight Technologies Ranks Among Fastest-Growing Companies in North America

The latest announcement is out from Hydreight Technologies Inc ( ($TSE:NURS) ). Hydreight Technologies Inc. has been ranked...

2M ago

Hydreight Technologies Ranks High in Growth and Expands Healthcare Network

Hydreight Technologies Inc ( ($TSE:NURS) ) has provided an announcement. Hydreight Technologies Inc. has been recognized for its...

3M ago

Hydreight Technologies Inc. Announces AGM Results and Executive Reappointments

Hydreight Technologies Inc ( ($TSE:NURS) ) has provided an announcement. At its 2025 Annual General Meeting, Hydreight Technologies...

4M ago

NURS FAQ

What was Hydreight Technologies Inc’s price range in the past 12 months?

Hydreight Technologies Inc lowest stock price was C$1.00 and its highest was C$5.59 in the past 12 months.

What is Hydreight Technologies Inc’s market cap?

Hydreight Technologies Inc’s market cap is C$135.01M.

When is Hydreight Technologies Inc’s upcoming earnings report date?

Hydreight Technologies Inc’s upcoming earnings report date is May 05, 2026 which is in 109 days.

How were Hydreight Technologies Inc’s earnings last quarter?

Hydreight Technologies Inc released its earnings results on Nov 26, 2025. The company reported C$0.01 earnings per share for the quarter, missing the consensus estimate of C$0.015 by -C$0.005.

Is Hydreight Technologies Inc overvalued?

According to Wall Street analysts Hydreight Technologies Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Hydreight Technologies Inc pay dividends?

Hydreight Technologies Inc does not currently pay dividends.

What is Hydreight Technologies Inc’s EPS estimate?

Hydreight Technologies Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hydreight Technologies Inc have?

Hydreight Technologies Inc has 29,673,117 shares outstanding.

What happened to Hydreight Technologies Inc’s price movement after its last earnings report?

Hydreight Technologies Inc reported an EPS of C$0.01 in its last earnings report, missing expectations of C$0.015. Following the earnings report the stock price went down -7.576%.

Which hedge fund is a major shareholder of Hydreight Technologies Inc?

Currently, no hedge funds are holding shares in TSE:NURS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Hydreight Technologies Inc Stock Smart Score

Outperform

Fundamentals

Return on Equity

0.18%

Trailing 12-Months

Asset Growth

222.93%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Hydreight Technologies Inc

Hydreight Technologies Inc provides health & wellness services. It offers a completely compliant turnkey business model for health professionals to offer fully licensed medical & health services. Its services include IV drip, Botox, COVID-19 testing, and other medical and medispa treatments at a location of the customer's choice.

Hydreight Technologies Inc (NURS) Earnings & Revenues

Historic Earnings Reports

NURS Stock 12 Month Forecast

Average Price Target

C$8.50

▲(86.81% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"C$0","9":"C$9","2.25":"C$2.25","4.5":"C$4.5","6.75":"C$6.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":8.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$8.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$8.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$8.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.25,4.5,6.75,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.43,3.8200000000000003,4.21,4.6,4.99,5.380000000000001,5.77,6.16,6.550000000000001,6.94,7.33,7.720000000000001,8.11,{"y":8.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.43,3.8200000000000003,4.21,4.6,4.99,5.380000000000001,5.77,6.16,6.550000000000001,6.94,7.33,7.720000000000001,8.11,{"y":8.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.43,3.8200000000000003,4.21,4.6,4.99,5.380000000000001,5.77,6.16,6.550000000000001,6.94,7.33,7.720000000000001,8.11,{"y":8.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.05,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.61,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.31,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.15,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.84,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.9,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.76,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.28,"date":1754006400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.28,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.3,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.82,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.43,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >